Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis

References

• Eksombatchai D, Jeong D, Mok J, et al. Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: a retrospective national cohort study. Int J Infect Dis. 2023;127:1–15. doi: 10.1016/j.ijid.2022.11.037.
   PubMed Web of Science ®Google Scholar
• Adane HT, Howe RC, Wassie L, et al. Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: a prospective health facility-based study. J Clin Tuberc Other Mycobact Dis. 2023;31:100368. doi: 10.1016/j.jctube.2023.100368.
   PubMedGoogle Scholar
• Al Amri S, Singh J, Al Balushi L, et al. Prevalence and associated factors of diabetes mellitus type 2 among tuberculosis patients in Muscat, Oman, 2017–2020. Oman Med J. 2023;38(4):e526.
   PubMedGoogle Scholar
• Shrestha N, Mishra SR, Ghimire S, et al. Burden of diabetes and prediabetes in Nepal: a systematic review and meta-analysis. Diabetes Ther. 2020;11(9):1935–1946. doi: 10.1007/s13300-020-00884-0.
   PubMed Web of Science ®Google Scholar
• Li M, Chen T, Hua Z, et al. Global, regional, and national prevalence of diabetes mellitus in patients with pulmonary tuberculosis: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):127. doi: 10.1186/s13098-021-00743-3.
   PubMed Web of Science ®Google Scholar
• Global Tuberculosis Report. Geneva: World Health Organization; 2020. Licence: CC by-NC-SA 3.0 IGO. Geneva, Switzerland: WHO; 2021.
   Google Scholar
• Wang CS, Yang CJ, Chen HC, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect. 2009;137(2):203–210. doi: 10.1017/S0950268808000782.
   PubMed Web of Science ®Google Scholar
• Yuan B, Du J, Lan X, et al. Effect of type 2 diabetes mellitus on sputum negative conversion and treatment effects of multi-drug-resistant tuberculosis. Biomed Res. 2017;28(9):3917–3922.
   Google Scholar
• Shewade HD, Jeyashree K, Mahajan P, et al. Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-diabetes: a systematic review. PLOS One. 2017;12(10):e0186697. doi: 10.1371/journal.pone.0186697.
   PubMed Web of Science ®Google Scholar
• Kyu HH, Maddison ER, Henry NJ, et al. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2018;18(3):261–284. doi: 10.1016/S1473-3099(17)30703-X.
   PubMed Web of Science ®Google Scholar
• Anyanwu MO, Ajumobi OO, Afolabi NB, et al. Diabetes mellitus and its associated factors among patients with tuberculosis attending directly observed treatment centres in Oyo State, Nigeria: a cross-sectional evaluation. BMJ Open. 2022;12(4):e059260. doi: 10.1136/bmjopen-2021-059260.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Collaborative framework for care and control of tuberculosis and diabetes. Geneva (Switzerland): World Health Organization; 2011.
   Google Scholar
• Ayeni FA, Oyetunde OO, Aina BA. The effect of collaborative care on treatment outcomes of newly diagnosed tuberculosis patients with type-2 diabetes mellitus and adverse drug reaction presentations: a prospective study. Int J Mycobacteriol. 2021;10(3):285–292. doi: 10.4103/ijmy.ijmy_124_21.
   PubMed Web of Science ®Google Scholar
• Moosazade M, Jamshidi M, Amiresmaili M, et al. A comparison of directly observed therapy and self-administered therapy strategies in treatment of pulmonary tuberculosis: a cohort study in North of Iran. Middle East J Sci Res. 2012;11(7):873–880.
   Google Scholar
• Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002;19(4):765–775. doi: 10.1183/09031936.02.00261402.
   PubMed Web of Science ®Google Scholar
• World Health Organization and S.T. Initiative. Treatment of tuberculosis: guidelines. Geneva (Switzerland): World Health Organization; 2010.
   Google Scholar
• Leung CC, Yew WW, Mok TYW, et al. Effects of diabetes mellitus on the clinical presentation and treatment response in tuberculosis. Respirology. 2017;22(6):1225–1232. doi: 10.1111/resp.13017.
   PubMed Web of Science ®Google Scholar
• Jeon CY, Harries AD, Baker MA, et al. Bi‐directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health. 2010;15(11):1300–1314. doi: 10.1111/j.1365-3156.2010.02632.x.
   PubMed Web of Science ®Google Scholar
• Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(1):81. doi: 10.1186/1741-7015-9-81.
   PubMed Web of Science ®Google Scholar
• Huangfu P, Ugarte-Gil C, Golub J, et al. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(7):783–796. doi: 10.5588/ijtld.18.0433.
   PubMed Web of Science ®Google Scholar
• Han X, Wang Q, Wang Y, et al. The impact of diabetes on tuberculosis treatment outcomes: evidence based on a cumulative meta-analysis. Int J Diabetes Dev Ctries. 2016;36(4):490–507. doi: 10.1007/s13410-016-0514-5.
   Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1–9. doi: 10.1186/2046-4053-4-1.
   PubMed Web of Science ®Google Scholar
• Chang J-T, Dou H-Y, Yen C-L, et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc. 2011;110(6):372–381. doi: 10.1016/S0929-6646(11)60055-7.
   PubMed Web of Science ®Google Scholar
• Viswanathan V, Vigneswari A, Selvan K, et al. Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis—a report from South India. J Diabetes Complicat. 2014;28(2):162–165. doi: 10.1016/j.jdiacomp.2013.12.003.
   PubMed Web of Science ®Google Scholar
• Satung J, Kaewkungwal J, Silachamroon U, et al. Treatment outcomes among diabetic patients with tuberculosis in Thailand. Southeast Asian J Trop Med Public Health. 2016;47(6):1209–1220.
   PubMed Web of Science ®Google Scholar
• Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis. 2007;45(4):428–435. doi: 10.1086/519841.
   PubMed Web of Science ®Google Scholar
• Ghanta J, Panja B, Goswami D, et al. The effect of diabetes mellitus on the treatment outcome of tuberculosis. Indian J Public Health Res Dev. 2023;14(2):107–114.
   Google Scholar
• Jiménez-Corona ME, Cruz-Hervert LP, García-García L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013;68(3):214–220. doi: 10.1136/thoraxjnl-2012-201756.
   PubMed Web of Science ®Google Scholar
• Yoon YS, Jung J-W, Jeon EJ, et al. The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study. Thorax. 2017;72(3):263–270. doi: 10.1136/thoraxjnl-2015-207686.
   PubMed Web of Science ®Google Scholar
• Prakash V. Impact of type 2 diabetes on manifestations of pulmonary tuberculosis and its treatment outcome. Roman J Diabetes Nutr Metab Dis. 2021;28(4):430–436.
   Google Scholar
• Kang YA, Kim SY, Jo K-W, et al. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis. Respiration. 2013;86(6):472–478. doi: 10.1159/000348374.
   PubMed Web of Science ®Google Scholar
• Siddiqui AN, Khayyam KU, Sharma M. Effect of diabetes mellitus on tuberculosis treatment outcome and adverse reactions in patients receiving directly observed treatment strategy in India: a prospective study. Biomed Res Int. 2016;2016:7273935. doi: 10.1155/2016/7273935.
   PubMed Web of Science ®Google Scholar
• Barss L, Sabur N, Orlikow E, et al. Diabetes mellitus in adult patients with active tuberculosis in Canada: presentation and treatment outcomes. Can J Respir Crit Care Sleep Med. 2019;3(2):84–90. doi: 10.1080/24745332.2018.1507615.
   Web of Science ®Google Scholar
• Delgado-Sánchez G, García-García L, Castellanos-Joya M, et al. Association of pulmonary tuberculosis and diabetes in Mexico: analysis of the National Tuberculosis Registry 2000–2012. PLOS One. 2015;10(6):e0129312. doi: 10.1371/journal.pone.0129312.
   PubMed Web of Science ®Google Scholar
• Ayeni F, Aina B, Oyetunde O, et al. Associated factors and treatment outcomes of tuberculosis patients with diabetes mellitus in a secondary health facility in Lagos Nigeria. West Afr J Pharm. 2016;27(1):1–9.
   Google Scholar
• Kornfeld H, Sahukar SB, Procter-Gray E, et al. Impact of diabetes and low body mass index on tuberculosis treatment outcomes. Clin Infect Dis. 2020;71(9):e392–e398. doi: 10.1093/cid/ciaa054.
   PubMed Web of Science ®Google Scholar
• Gil-Santana L, Almeida-Junior JL, Oliveira CAM, et al. Diabetes is associated with worse clinical presentation in tuberculosis patients from Brazil: a retrospective cohort study. PLOS One. 2016;11(1):e0146876. doi: 10.1371/journal.pone.0146876.
   PubMed Web of Science ®Google Scholar
• Magee MJ, Kempker RR, Kipiani M, et al. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia. PLOS One. 2014;9(4):e94890. doi: 10.1371/journal.pone.0094890.
   PubMed Web of Science ®Google Scholar
• Mukhtar F, Butt ZA. Risk of adverse treatment outcomes among new pulmonary TB patients co-infected with diabetes in Pakistan: a prospective cohort study. PLOS One. 2018;13(11):e0207148. doi: 10.1371/journal.pone.0207148.
   PubMed Web of Science ®Google Scholar
• Chiang CY, Bai KJ, Lin HH, et al. The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PLOS One. 2015;10(3):e0121698. doi: 10.1371/journal.pone.0121698.
   PubMed Web of Science ®Google Scholar
• Magee MJ, Kempker RR, Kipiani M, et al. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia. Int J Tuberc Lung Dis. 2015;19(6):685–692. doi: 10.5588/ijtld.14.0811.
   PubMed Web of Science ®Google Scholar
• Muñoz-Torrico M, Caminero-Luna J, Migliori GB, et al. Diabetes is associated with severe adverse events in multidrug-resistant tuberculosis. Arch Bronconeumol. 2017;53(5):245–250. doi: 10.1016/j.arbr.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Perez-Navarro LM, Restrepo BI, Fuentes-Dominguez FJ, et al. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes. Tuberculosis. 2017;103:83–91. doi: 10.1016/j.tube.2017.01.006.
   PubMed Web of Science ®Google Scholar
• Sembiah S, Nagar V, Gour D, et al. Diabetes in tuberculosis patients: an emerging public health concern and the determinants and impact on treatment outcome. J Family Community Med. 2020;27(2):91–96. doi: 10.4103/jfcm.JFCM_296_19.
   PubMed Web of Science ®Google Scholar
• Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, et al. The effect of diabetes and prediabetes on antituberculosis treatment outcomes: a multicenter prospective cohort study. J Infect Dis. 2022;225(4):617–626.
   PubMed Web of Science ®Google Scholar
• Sulaiman SAS, Khan AH, Ahmad N, et al. Impact of diabetes mellitus on treatment outcomes of tuberculosis patients in tertiary care setup. Am J Med Sci. 2013;345(4):321–325. doi: 10.1097/MAJ.0b013e318288f8f3.
   PubMed Web of Science ®Google Scholar
• Rout P, Jagaty S, Behera D, et al. Impact of diabetes mellitus on treatment outcome of newly diagnosed smear-positive pulmonary tuberculosis patients: a case–control study. Med J Dr D Y Patil Vidyapeeth. 2023;16(7):S47–S50.
   Google Scholar
• Sahakyan S, Petrosyan V, Abrahamyan L. Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study. Int J Public Health. 2020;65(1):37–43. doi: 10.1007/s00038-019-01277-2.
   PubMed Web of Science ®Google Scholar
• Lee EH, Lee JM, Kang YA, et al. Prevalence and impact of diabetes mellitus among patients with active pulmonary tuberculosis in South Korea. Lung. 2017;195(2):209–215. doi: 10.1007/s00408-017-9978-4.
   PubMed Web of Science ®Google Scholar
• Haile Workneh M, Aksel Bjune G, Abebe Yimer S. Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia. Infect Dis Poverty. 2016;5(2):22. doi: 10.1186/s40249-016-0115-z.
   PubMedGoogle Scholar
• You N, Pan H, Zeng Y, et al. A risk score for prediction of poor treatment outcomes among tuberculosis patients with diagnosed diabetes mellitus from Eastern China. Sci Rep. 2021;11(1):11219. doi: 10.1038/s41598-021-90664-y.
   PubMed Web of Science ®Google Scholar
• Hongguang C, Min L, Shiwen J, et al. Impact of diabetes on clinical presentation and treatment outcome of pulmonary tuberculosis in Beijing. Epidemiol Infect. 2015;143(1):150–156. doi: 10.1017/S095026881400079X.
   PubMed Web of Science ®Google Scholar
• Mahato RK, Laohasiriwong W, Koju R. The role of diabetes mellitus comorbidity on tuberculosis treatment outcomes in Nepal: a prospective cohort study. South East Eur J Public Health. 2023. doi: 10.56801/seejph.vi.260.
   Google Scholar
• Lin Y, Bai Y, Zhang T, et al. Unfavourable treatment outcomes in tuberculosis patients with different vitamin D status and blood glucose levels in a programme setting in China. Trop Med Int Health. 2020;25(3):373–379. doi: 10.1111/tmi.13355.
   PubMed Web of Science ®Google Scholar
• Wu Z, Guo J, Huang Y, et al. Diabetes mellitus in patients with pulmonary tuberculosis in an aging population in Shanghai, China: prevalence, clinical characteristics and outcomes. J Diabetes Complicat. 2016;30(2):237–241. doi: 10.1016/j.jdiacomp.2015.11.014.
   PubMed Web of Science ®Google Scholar
• Mi F, Tan S, Liang L, et al. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two‐month smear conversion and treatment outcomes in Guangzhou, China. Trop Med Int Health. 2013;18(11):1379–1385. doi: 10.1111/tmi.12198.
   PubMed Web of Science ®Google Scholar
• Nandakumar KV, Duraisamy K, Balakrishnan S, et al. Outcome of tuberculosis treatment in patients with diabetes mellitus treated in the revised national tuberculosis control programme in Malappuram District, Kerala, India. PLOS One. 2013;8(10):e76275. doi: 10.1371/journal.pone.0076275.
   PubMed Web of Science ®Google Scholar
• Mave V, Gaikwad S, Barthwal M, et al. Diabetes mellitus and tuberculosis treatment outcomes in Pune, India. Open Forum Infect Dis. 2021;8(4):ofab097. doi: 10.1093/ofid/ofab097.
   PubMed Web of Science ®Google Scholar
• Choi S-I, Lee SC, Kong SJ, et al. The effect of diabetes mellitus on treatment outcomes in pulmonary tuberculosis. Korean J Med. 2003;65:558–567.
   Google Scholar
• Xhardo HE, Hysenbelli B, Ylli D, et al. Prevalence and impact of diabetes mellitus in adult tuberculosis patients: a cross-sectional study. Endocr Abstr. 2023. doi: 10.1530/endoabs.90.P341.
   Google Scholar
• Baltas I, Sturdy A, Kavallieros K, et al. Diabetes mellitus is not a predictor of poor TB treatment outcomes. Int J Tuberc Lung Dis. 2023;27(2):140–145. doi: 10.5588/ijtld.22.0470.
   PubMed Web of Science ®Google Scholar
• Tok PSK, Liew SM, Wong LP, et al. Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: a registry-based ­cohort study. PLOS One. 2020;15(4):e0231986. doi: 10.1371/journal.pone.0231986.
   PubMed Web of Science ®Google Scholar
• Alebel A, Wondemagegn AT, Tesema C, et al. Prevalence of diabetes mellitus among tuberculosis patients in sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2019;19(1):254. doi: 10.1186/s12879-019-3892-8.
   PubMedGoogle Scholar
• World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision: updated December 2014 and January 2020. Geneva (Switzerland): World Health Organization; 2013.
   Google Scholar
• Ruslami R, Aarnoutse RE, Alisjahbana B, et al. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health. 2010;15(11):1289–1299. doi: 10.1111/j.1365-3156.2010.02625.x.
   PubMed Web of Science ®Google Scholar
• Singla R, Khan N, Al-Sharif N, et al. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis. 2006;10(1):74–79.
   PubMed Web of Science ®Google Scholar
• Khanna A, Lohya S, Sharath BN, et al. Characteristics and treatment response in patients with tuberculosis and diabetes mellitus in New Delhi, India. Public Health Action. 2013;3(Suppl. 1):S48–S50. doi: 10.5588/pha.13.0025.
   PubMedGoogle Scholar
• Chiang CY, Lee J-J, Yu M-C, et al. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis. 2009;13(1):105–111.
   PubMed Web of Science ®Google Scholar
• Vasankari T, Holmström P, Ollgren J, et al. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health. 2007;7(1):291. doi: 10.1186/1471-2458-7-291.
   PubMedGoogle Scholar
• Gautam S, Shrestha N, Mahato S, et al. Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis. Sci Rep. 2021;11(1):2113. doi: 10.1038/s41598-021-81057-2.
   PubMed Web of Science ®Google Scholar
• Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152. doi: 10.1371/journal.pmed.0050152.
   PubMed Web of Science ®Google Scholar
• Al-Attiyah R, Mustafa A. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette–Guérin (BCG)-vaccinated healthy subjects. Clin Exp Immunol. 2009;158(1):64–73. doi: 10.1111/j.1365-2249.2009.04000.x.
   PubMed Web of Science ®Google Scholar
• Restrepo BI, Fisher-Hoch SP, Pino PA, et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis. 2008;47(5):634–641. doi: 10.1086/590565.
   PubMed Web of Science ®Google Scholar